US FDA Panel Backs Shionogi’s Novel Antibiotic

Shionogi won the blessing of a US FDA advisory panel on October 16 for its novel antibiotic cefiderocol for the treatment of complicated urinary tract infections (cUTIs), the company said. The FDA’s Antimicrobial Drugs Advisory Committee voted in favor of...read more